BCWORLD PHARM. Co., Ltd. Stock: price and insider trades · South Korea

This page follows insider dealings at BCWORLD PHARM. Co., Ltd. as filed with DART (FSS), a company from the Health Care sector. Over the twelve months to 2 November 2026, 13 filings were filed, from 4 insiders.

Both sides are active: 7 purchases worth €901k and 1 sale, from 4 insiders and 1 insider respectively. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives and 1 chief executive. The largest single trade was a purchase of €838k by 홍성한, published on 14 April 2026, equal to 4.4% of the market capitalisation.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 13 filings, this issuer sits above that mark. Since 2022, the database holds 12 purchases and 1 sale by insiders of the company.

The data flag 5 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 14 April 2026, 208 days ago. Typically, a trade is published a median of 6 days after it takes place. That lag is the time during which only the insider knows about the trade.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.